Inactive Instrument

Santarus, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	RE
2013	Santarus, Inc. : Salix bolsters gastro drug line-up with $2.6 billion Santarus buy	RE

The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	13-11-08	RE
Santarus, Inc. : Salix bolsters gastro drug line-up with $2.6 billion Santarus buy	13-11-07	RE

Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	13-12-31	PR
Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	13-12-30	BU
Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	13-12-23	BU
Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	13-11-11	PR
Santarus, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders	13-11-08	BU

Sector

	1st Jan change	Capi.
CSL LIMITED	-2.83%	88.12B
SAMSUNG BIOLOGICS CO.,LTD.	+4.34%	40.6B
BIOGEN INC.	-23.95%	28.81B
UCB	+51.39%	24.35B
BIOMARIN PHARMACEUTICAL INC.	-5.09%	17.5B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-32.11%	13.54B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-5.10%	13.52B
INCYTE CORPORATION	-14.91%	12.09B
SWEDISH ORPHAN BIOVITRUM AB	-4.79%	7.88B